The GLP-1 pills work similarly, but these contain a higher dose of medication to compensate for absorption into the digestive ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Weight loss medication Wegovy is now available in pill form, offering the same active ingredient as weekly injections.

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking ...